GlobeNewswire Inc | Sep 21, 2021 04:01PM EDT

September 21, 2021

HAMILTON, Bermuda, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that it will present atthe 2021 Cantor Fitzgerald Virtual Global Healthcare Conference onTuesday, September 28, 2021 at 10:40 a.m. Eastern Time.

A live webcast of Kiniksas presentation will be accessible through the Investors & Media section of the companys website at www.kiniksa.com. A replay of the webcast will also be available on Kiniksas website within approximately 48 hours after the event.

About KiniksaKiniksa is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksas portfolio of assets, ARCALYST (rilonacept), mavrilimumab, vixarelimab and KPL-404, are based on strong biologic rationale or validated mechanisms, target underserved conditions and offer the potential for differentiation. These assets are designed to modulate immunological pathways across a spectrum of diseases. For more information, please visitwww.kiniksa.com.

ARCALYSTis a registered trademark ofRegeneron Pharmaceuticals,Inc.

Every Second Counts!

Kiniksa Investor and Media ContactRachel Frank(339) 970-9437rfrank@kiniksa.com